PD-L1 Expression is Related to Tumor Staging in NSCLC

被引：0
|
作者：
Wang, Hangjun
Agulnik, Jason [1 ,2 ]
Kasymjanova, Goulnar [3 ]
Wang, Anna Y. [1 ,2 ]
Cohen, Victor [1 ,2 ]
Small, David [1 ,2 ]
Pepe, Carmela [1 ,2 ]
Sakr, Lama [1 ,2 ]
Fiset, Pierre O. [4 ]
Auger, Manon
Camilleri-Broet, Sophie [2 ,4 ]
Alameldin, Mona [2 ,4 ]
Chong, George [2 ,4 ]
van Kempen, Leon [2 ,4 ]
Spatz, Alan [2 ,4 ]
机构：
[1] Jewish Gen Hosp, Montreal, PQ, Canada
[2] McGill Univ, Montreal, PQ, Canada
[3] JGH, Montreal, PQ, Canada
[4] McGill Univ, Hlth Ctr, Glen Site, Montreal, PQ, Canada
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
2114
引用
收藏
页码：755 / 755
页数：1
相关论文
共 50 条
  • [31] Various impacts of driver mutations on the PD-L1 expression of NSCLC
    Chu, Cheng-Hsiang
    Huang, Yen-Hsiang
    Lee, Po-Hsin
    Hsu, Kuo-Hsuan
    Chen, Kun-Chieh
    Su, Kang-Yi
    Yu, Sung-Liang
    Tseng, Jeng-Sen
    Yang, Tsung-Ying
    Chang, Gee-Chen
    PLOS ONE, 2022, 17 (08):
  • [32] Correlation between PD-L1 expression and clinicopathological characterization in NSCLC
    Jin, Y.
    ANNALS OF ONCOLOGY, 2018, 29 : 143 - 143
  • [33] Prevalence of PD-L1 Expression Rates in Different NSCLC Specimens
    Holmes, M.
    Mahar, A.
    Lum, T.
    Boyer, M.
    Kao, S.
    Cooper, W.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S506 - S506
  • [34] Expression status of PD-L1 in NSCLC correlates with disease extension
    Yamamoto, Aya
    Iwata, Takashi
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [35] PD-L1 expression in NSCLC and the comparison with the other types of cancer
    Acar, E.
    Akyurek, N.
    VIRCHOWS ARCHIV, 2018, 473 : S311 - S311
  • [36] EBUS-TBNA in Assessing PD-L1 Expression in NSCLC
    Agulnik, J.
    Kasymjanova, G.
    Wang, H.
    Sakr, L.
    Small, D.
    Cohen, V.
    Spatz, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S387 - S387
  • [37] YAP regulates PD-L1 expression in human NSCLC cells
    Miao, Jinbai
    Hsu, Ping-Chih
    Yang, Yi-Lin
    Xu, Zhidong
    Dai, Yuyuan
    Wang, Yucheng
    Chan, Geraldine
    Huang, Zhen
    Hu, Bin
    Li, Hui
    Jablons, David M.
    You, Liang
    ONCOTARGET, 2017, 8 (70) : 114576 - 114587
  • [38] Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells
    Zhang, Xiaoqing
    Cheng, Chen
    Hou, Jiyan
    Qi, Xinyue
    Wang, Xin
    Han, Ping
    Yang, Xuanming
    CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 16 (04) : 392 - 400
  • [39] KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC
    Li, Jinghan
    Shi, Daiwang
    Li, Siyi
    Shi, Xiang
    Liu, Yu
    Zhang, Yi
    Wang, Gebang
    Zhang, Chenlei
    Xia, Tian
    Piao, Hai-long
    Liu, Hong-Xu
    CELL DEATH & DISEASE, 2024, 15 (02)
  • [40] PD-L1 Expression on Cytological Imprints and Circulating Tumor Cells versus Standardized Immunohistochemistry in NSCLC
    Abdo, M.
    Belloum, Y.
    Heigener, D.
    Welker, L.
    Schmidt, M.
    Heuer-Olewinski, N.
    Elmas, H.
    Perner, S.
    Wikman, H.
    Pantel, K.
    Reck, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S559 - S560
12345